Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Roivant Sciences ( (ROIV) ) is now available.
Roivant Sciences Ltd. has announced a new common share repurchase program on June 24, 2025, allowing for the repurchase of up to $500 million of its common shares. This initiative follows a previous $1.5 billion repurchase program from April 2024, which has been fully utilized. The repurchase will be funded with available cash, with no set expiration date, and will depend on market conditions and other factors.
The most recent analyst rating on (ROIV) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Roivant Sciences stock, see the ROIV Stock Forecast page.
Spark’s Take on ROIV Stock
According to Spark, TipRanks’ AI Analyst, ROIV is a Neutral.
Roivant Sciences’ stock score is primarily influenced by its financial struggles and valuation concerns, which are mitigated by promising pipeline developments and strategic corporate actions. The company’s strong cash position and potential market advancements provide a balanced outlook despite significant risks.
To see Spark’s full report on ROIV stock, click here.
More about Roivant Sciences
Average Trading Volume: 6,417,097
Technical Sentiment Signal: Strong Buy
Current Market Cap: $7.84B
For an in-depth examination of ROIV stock, go to TipRanks’ Overview page.